quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:19:18·836d
SECFiling
Talaris Therapeutics Inc. logo

Talaris Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

TALS· Talaris Therapeutics Inc.
Health Care
Original source

Companies

  • TALS
    Talaris Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Oct 20UpdateH.C. Wainwright$18.00
  • Jul 5UpdateMorgan Stanley$8.00
  • Nov 12UpdateSVB Leerink$22.00

Related

  • 13D/G799d
    SEC Form SC 13G/A filed by Talaris Therapeutics Inc. (Amendment)
  • 13D/G799d
    SEC Form SC 13G filed by Talaris Therapeutics Inc.
  • 13D/G799d
    SEC Form SC 13G/A filed by Talaris Therapeutics Inc. (Amendment)
  • 13D/G799d
    SEC Form SC 13G/A filed by Talaris Therapeutics Inc. (Amendment)
  • 13D/G804d
    SEC Form SC 13G/A filed by Talaris Therapeutics Inc. (Amendment)
  • 13D/G804d
    SEC Form SC 13G filed by Talaris Therapeutics Inc.
  • 13D/G806d
    SEC Form SC 13G/A filed by Talaris Therapeutics Inc. (Amendment)
  • INSIDER813d
    Mcdade Mark bought $3,250,000 worth of shares (100,000 units at $32.50) (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022